Also, in MM, high miRNA-221/222 was linked with low sensitivity to melphalan, and inhibitors of these miRNAs were able to restore sensitivity to this treatment in both MM cell lines and melphalan-refractory MM xenografts, in part due to modulation of the miRNA-221/222 target PUMA [114]. Here, BBC3 is linked to Miyoshi myopathy.